Capital Flow Monitor · Sponsors · CIK 2156954

Uvantis Therapeutics, Inc.

10980 GRANTCHESTER WAY, COLUMBIA, MD, 21044 · 6174176695

Biotechnology · Corporation· inc. DELAWARE true 2025

Fit score

—

Offering

$5.0M

Sold

$100K

% sold

2.0%

Investors

1

Min investment

$0

Exemption

506(b)

Filing history

FiledFormRuleOfferingSold% soldInvestors
2026-09-23 D ·current 506(b) $5.0M $100K 2.0% 1 EDGAR ↗

Related persons

Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.

Placement agents

  • No sales compensation reported — direct raise.

Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.